Telogen Effluvium and Alopecia Areata as Clinical Manifestations of COVID-19

April 2022 in “ Research review ”

Laura Camila Garcia Medina

We don't know much about this study yet.

View this study on jmrhs.info →

Discuss this study in the Community →

Related Community Posts Join

6 / 1000+ results

community Covid (likely) induced alopecia areata - now 2nd round of Covid, what can I expect?

1 upvotes 3 years ago

After experiencing hair loss due to alopecia areata following COVID-19 vaccination and infection, the individual saw improvement with steroid treatments and Olumiant. They paused Olumiant during a second COVID-19 infection and expressed concern about potential hair loss flare-ups.

community Hair loss after COVID or vaccination isn’t “made up” but it’s also not what TikTok makes it sound like

2 upvotes 7 months ago

COVID and COVID vaccination can trigger hair loss, primarily telogen effluvium, due to stress and immune system activation. Proper diagnosis and addressing factors like nutrition and stress are crucial for recovery.

community Am I crazy or is this recovery?

in Is this regrowth? 134 upvotes 1 year ago

The user is experiencing sudden hair loss and is considering micro-needling, low-level light therapy, iron supplements, folihair, and Omega 3. They are hesitant to start finasteride, suspecting the hair loss might be due to telogen effluvium from a past COVID-19 infection.

community Mexican balding victim here, 3 months

in Is this regrowth? 49 upvotes 1 year ago

A user started using oral minoxidil (2.5 mg) and dutasteride (1 mg) for hair loss three months ago and noticed no side effects, possibly due to regular exercise. They speculate a possible link between COVID-19 and accelerated hair loss.

community Do I have Alopecia Areata, TE or MPB?

2 upvotes 4 years ago

community What should I do in my situation? (Aga and suspected aai, and body inompatible with dht blockers)

1 upvotes 2 weeks ago

The user experienced hair loss after a COVID vaccine, suspected alopecia areata incognito, and tried treatments like minoxidil, finasteride, and dutasteride, but faced side effects like gynecomastia. They are unable to use DHT blockers due to sensitivity and continue to lose hair with receding hairline and low density.

Related Research

5 / 5 results

research Severe COVID-19 Infection Predisposes Patients to Greater Burden of Hair Loss

April 2023 in “Journal of Investigative Dermatology”

This study observed that 6.5% of COVID-19 patients requiring inpatient or emergency care developed hair loss, compared to 4.7% of those treated as outpatients, suggesting COVID-19 severity may influence hair loss risk.

A Preliminary Observation: Male Pattern Hair Loss Among Hospitalized COVID-19 Patients in Spain – A Potential Clue to the Role of Androgens in COVID-19 Severity

research A Preliminary Observation: Male Pattern Hair Loss Among Hospitalized COVID-19 Patients in Spain – A Potential Clue to the Role of Androgens in COVID-19 Severity

134 citations , April 2020 in “Journal of Cosmetic Dermatology”

Male pattern hair loss could hint at androgens affecting COVID-19 severity.

research Alopecia Areata: Clinical Presentation, Diagnosis, and Unusual Cases

109 citations , May 2011 in “Dermatologic Therapy”

This article reviews the characteristics, associations, and diagnostic criteria for alopecia areata and reports no new clinical findings; the authors note the disease's unpredictable course and variable prognosis.

research Diagnosis of Hair Loss: Clinical Features of Common Causes

1 citations , April 1992 in “PubMed”

This review discusses the clinical features of various types of hair loss, including both common and less common alopecias, and reports no new clinical results.

research Diagnosis and Management of the Hair Loss Patient

7 citations , September 1987 in “PubMed”

This paper reviews the main causes of hair loss seen by dermatologists and reports no new clinical findings, emphasizing the need for comprehensive understanding to manage these conditions effectively.